Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1970 Mar 28;1(5699):773–778. doi: 10.1136/bmj.1.5699.773

Depressive Illness in a General Practice. A Demographic Study and a Controlled Trial of Imipramine

A M W Porter
PMCID: PMC1699663  PMID: 4910188

Abstract

The distribution of 93 consecutive cases of depressive illness in a Surrey general practice was found to be non-random. Married women were at risk, while men and unmarried women were largely spared. Married women were prone to the disorder at any time in their lives, and relapse was frequent. There was some suggestion that divorced wives and wives of low social class were particularly predisposed to the disorder.

Sixty of the patients took part in a double-blind controlled trial of imipramine. There was no evidence that the drug was superior to a placebo in inducing a remission. It is suggested that imipramine has become established in clinical practice on inadequate evidence and that there is a need for further trials.

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAHAM H. C., KANTER V. B., ROSEN I., STANDEN J. L. A controlled clinical trial of imipramine (Tofranil) with out-patients. Br J Psychiatry. 1963 Mar;109:286–293. doi: 10.1192/bjp.109.459.286. [DOI] [PubMed] [Google Scholar]
  2. AGNEW P. C., BARAN I. D., KLAPMAN H. J., REID F. T., Jr, STERN J. J., SLUTSKE R. H. A clinical evaluation of four antidepressant drugs (nardil, tofranil, marplan, and deprol). Am J Psychiatry. 1961 Aug;118:160–162. doi: 10.1176/ajp.118.2.160. [DOI] [PubMed] [Google Scholar]
  3. ASHBY W. R., COLLINS G. H. A clinical trial of imipramine ("Tofranil") on depressed patients. J Ment Sci. 1961 May;107:547–551. doi: 10.1192/bjp.107.448.547. [DOI] [PubMed] [Google Scholar]
  4. BALL J. R., KILOH L. G. A controlled trial of imipramine in treatment of depressive states. Br Med J. 1959 Nov 21;2(5159):1052–1055. doi: 10.1136/bmj.2.5159.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BASSA D. M., VORO H. D. EVALUATION OF EFFICACY OF IMIPRAMINE IN DEPRESSIVE DISORDERS: A DOUBLE-BLIND STUDY. Am J Psychiatry. 1965 May;121:1116–1117. doi: 10.1176/ajp.121.11.1116. [DOI] [PubMed] [Google Scholar]
  6. BODKIN N. J., GAZE R. B., GOMEZ G., HOWLETT M. J., LEIGH D. The general practitioner and the psychiatrist; a study in cooperation. Br Med J. 1953 Sep 26;2(4838):723–725. doi: 10.1136/bmj.2.4838.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. COOPER B., BROWN A. C., KALTON G. A pilot study of psychiatric morbidity in general practice. J Coll Gen Pract. 1962 Nov;5:590–602. [PMC free article] [PubMed] [Google Scholar]
  8. COPPEN A. THE PREVALENCE OF MENSTRUAL DISORDERS IN PSYCHIATRIC PATIENTS. Br J Psychiatry. 1965 Feb;111:155–167. doi: 10.1192/bjp.111.471.155. [DOI] [PubMed] [Google Scholar]
  9. Chiazze L., Jr, Brayer F. T., Macisco J. J., Jr, Parker M. P., Duffy B. J. The length and variability of the human menstrual cycle. JAMA. 1968 Feb 5;203(6):377–380. [PubMed] [Google Scholar]
  10. Coppen A., Shaw D. M., Malleson A., Costain R. Mineral metabolism in mania. Br Med J. 1966 Jan 8;1(5479):71–75. doi: 10.1136/bmj.1.5479.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DALTON K. Menstruation and acute psychiatric illnesses. Br Med J. 1959 Jan 17;1(5115):148–149. doi: 10.1136/bmj.1.5115.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DANEMAN E. A. Imipramine in office management of depressive reactions. (A double blind clinical study). Dis Nerv Syst. 1961 Apr;22:213–217. [PubMed] [Google Scholar]
  13. FRIEDMAN C., DE MOWBRAY M. S., HAMILTON V. Imipramine (Tofranil) in depressive states: a controlled trial with inpatients. J Ment Sci. 1961 Sep;107:948–953. doi: 10.1192/bjp.107.450.948. [DOI] [PubMed] [Google Scholar]
  14. FRY J. A year of general practice; a study in morbidity. Br Med J. 1952 Aug 2;2(4778):249–252. doi: 10.1136/bmj.2.4778.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Friedman A. S., Granick S., Cohen H. W., Cowitz B. Imipramine (Tofranil vs. placebo in hospitalized psychotic depressives. (a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores). J Psychiatr Res. 1966 Jul;4(1):13–36. doi: 10.1016/0022-3956(66)90012-4. [DOI] [PubMed] [Google Scholar]
  16. HOHN R., GROSS G. M., GROSS M., LASAGNA L. A doubleblind comparison of placebo and imipramine in the treatment of depressed patients in a state hospital. J Psychiatr Res. 1961 Oct;1:76–91. doi: 10.1016/0022-3956(61)90008-5. [DOI] [PubMed] [Google Scholar]
  17. HOLDWAY V. Trial of imipramine. J Ment Sci. 1960 Oct;106:1443–1446. doi: 10.1192/bjp.106.445.1443. [DOI] [PubMed] [Google Scholar]
  18. IRVINE D. G., MIYASHITA H. BLOOD TYPES IN RELATION TO DEPRESSIONS AND SCHIZOPHRENIA: A PRELIMINARY REPORT. Can Med Assoc J. 1965 Mar 13;92:551–554. [PMC free article] [PubMed] [Google Scholar]
  19. KENNING I. S., RICHARDSON N. L., TUCKER F. G. The treatment of depressive states with impiramine hydrochloride. Can Psychiatr Assoc J. 1960 Jan;5:60–64. doi: 10.1177/070674376000500114. [DOI] [PubMed] [Google Scholar]
  20. KESSEL N., SHEPHERD M. Neurosis in hospital and general practice. J Ment Sci. 1962 Mar;108:159–166. doi: 10.1192/bjp.108.453.159. [DOI] [PubMed] [Google Scholar]
  21. LEHMANN H. E., CAHN C. H., DE VERTEUIL R. L. The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J. 1958 Oct;3(4):155–164. doi: 10.1177/070674375800300401. [DOI] [PubMed] [Google Scholar]
  22. LEIGH D. Domiciliary consultation in psychiatric practice; analysis of 1000 visits. Lancet. 1955 Dec 17;269(6903):1285–1287. doi: 10.1016/s0140-6736(55)93070-1. [DOI] [PubMed] [Google Scholar]
  23. LEYBERG J. T., DENMARK J. C. The treatment of depressive states with imipramine hydrochloride (tofranil). J Ment Sci. 1959 Oct;105:1123–1126. doi: 10.1192/bjp.105.441.1123. [DOI] [PubMed] [Google Scholar]
  24. MACKINNON P. C., MACKINNON I. L. Hazards of the menstrual cycle. Br Med J. 1956 Mar 10;1(4966):555–555. doi: 10.1136/bmj.1.4966.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. MANUILA A. Blood groups and disease-hard facts and delusions. J Am Med Assoc. 1958 Aug 23;167(17):2047–2053. doi: 10.1001/jama.1958.02990340007002. [DOI] [PubMed] [Google Scholar]
  26. MILLER A., BAKER E. F., LEWIS D., JONES A. Imipramine, a clinical evaluation in a variety of settings. Can Psychiatr Assoc J. 1960 Jul;5:150–160. doi: 10.1177/070674376000500303. [DOI] [PubMed] [Google Scholar]
  27. MacKinnon A. U. Depression in one practice. Practitioner. 1966 Mar;196(173):420–423. [PubMed] [Google Scholar]
  28. OLTMAN J. E., FRIEDMAN S. RELAPSES FOLLOWING TREATMENT WITH ANTIDEPRESSANT DRUGS. Dis Nerv Syst. 1964 Nov;25:699–701. [PubMed] [Google Scholar]
  29. PARKER J. B., THEILIE A., SPIELBERGER C. D. Frequency of blood types in a homogeneous group of manic-depressive patients. J Ment Sci. 1961 Sep;107:936–942. doi: 10.1192/bjp.107.450.936. [DOI] [PubMed] [Google Scholar]
  30. PATCH I. C., POST F., SLATER P. CONSTITUTION AND THE PSYCHIATRY OF OLD AGE. Br J Psychiatry. 1965 May;111:405–413. doi: 10.1192/bjp.111.474.405. [DOI] [PubMed] [Google Scholar]
  31. Porter A. M. Body height and imipramine side-effects. Br Med J. 1968 May 18;2(5602):406–407. doi: 10.1136/bmj.2.5602.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Porter A. M. Drug defaulting in a general practice. Br Med J. 1969 Jan 25;1(5638):218–222. doi: 10.1136/bmj.1.5638.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Porter A. M. Peripatetic patients. Practitioner. 1966 Aug;197(178):229–230. [PubMed] [Google Scholar]
  34. REES L., BROWN A. C., BENAIM S. A controlled trial of imipramine ("Tofranil") in the treatment of severe depressive states. J Ment Sci. 1961 May;107:552–559. doi: 10.1192/bjp.107.448.552. [DOI] [PubMed] [Google Scholar]
  35. ROBIN A. A., LANGLEY G. E. A CONTROLLED TRIAL OF IMIPRAMINE. Br J Psychiatry. 1964 May;110:419–422. doi: 10.1192/bjp.110.466.419. [DOI] [PubMed] [Google Scholar]
  36. ROTHMAN T., GRAYSON H., FERGUSON J. A comparative investigation of isocarboxazid and imipramine in depressive syndromes. J Neuropsychiatr. 1961 Jan-Feb;2:158–162. [PubMed] [Google Scholar]
  37. ROULET N., ALVAREZ R. R., DUFFY J. P., LENKOSKI L. D., BIDDER T. G. Imipramine in depression: a controlled study. Am J Psychiatry. 1962 Nov;119:427–431. doi: 10.1176/ajp.119.5.427. [DOI] [PubMed] [Google Scholar]
  38. SLOANE R. B., HABIB A., BATT U. E. The use of imipramine (tofranil) for depressive states in open ward settings of a general hospital: a preliminary report. Can Med Assoc J. 1959 Apr 1;80(7):540–546. [PMC free article] [PubMed] [Google Scholar]
  39. SORENSEN H. R. Primary isolated nodular amyloidosis of the lung. Acta Chir Scand Suppl. 1961;Suppl 283:162–167. [PubMed] [Google Scholar]
  40. Schorer C. E., Lowinger P., Dobie S. The real effect of imipramine, isocarboxazid and nialamide. Mich Med. 1966 Dec;65(12):1071–1075. [PubMed] [Google Scholar]
  41. Silverman C. The epidemiology of depression. A review. Am J Psychiatry. 1968 Jan;124(7):883–891. doi: 10.1176/ajp.124.7.883. [DOI] [PubMed] [Google Scholar]
  42. WATTS C. A. The incidence and prognosis of endogenous depression. Br Med J. 1956 Jun 16;1(4980):1392–1397. doi: 10.1136/bmj.1.4980.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. WITTENBORN J. R., PLANTE M., BURGESS F., MAURER H. A comparison of imipramine, electroconvulsive therapy and placebo in the treatment of depressions. J Nerv Ment Dis. 1962 Aug;135:131–137. doi: 10.1097/00005053-196208000-00006. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES